Standout Papers

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with... 2017 2026 2020 2023 379
  1. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer (2017)
    Stephen Bagley, Shawn Kothari et al. Lung Cancer

Immediate Impact

3 by Nobel laureates 3 from Science/Nature 63 standout
Sub-graph 1 of 24

Citing Papers

Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
2 intermediate papers

Works of Peter Gabriel being referenced

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
2017 Standout
Feasibility Study of an Electronic Interface Between Internet-Based Survivorship Care Plans and Electronic Medical Records
2016

Author Peers

Author Last Decade Papers Cites
Peter Gabriel 667 597 133 208 92 1.7k
Xiaofei Wang 834 1223 74 195 89 2.1k
Lars R. Holsti 554 687 38 231 71 1.6k
Amol Narang 1170 689 95 333 135 2.0k
Stefano Ferretti 1119 371 140 141 115 2.1k
Abigail T. Berman 692 1140 85 446 102 1.9k
Antonio Ghidini 1384 673 65 127 86 2.2k
Randall Hughes 609 858 22 242 42 1.4k
Arya Amini 660 961 46 343 153 1.8k
Xiaoqiang Li 482 537 22 89 83 1.6k
Yue‐Ping Liu 722 213 31 113 75 1.3k

All Works

Loading papers...

Rankless by CCL
2026